Homatropine 2%
Generic name
Homatropine 2%
Brand name
ATC Code
S01FA05
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Pupil dilation |
|---|
|
| Partial cataract |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Systemic side effects can occur, above all in children.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
MYDRIATICS AND CYCLOPLEGICS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Anticholinergics | ||
|---|---|---|
| S01FA01 | ||
| S01FA04 | ||
| S01FA06 | ||
Reference
- Ratiopharm BV, SPC Homatropine (RVG 57666), www.cbg-meb.nl, Geraadpleegd 4 juni 2010, http://db.cbg-meb.nl/IB-teksten/h57666.pdf
Changes
Therapeutic Drug Monitoring
Overdose
